Publications

Showing

0

out of

0

results

ENSEMBLE PLUS: final results of shorter ocrelizumab infusion from a randomized controlled trial

Hartung HP, Berger T, Bermel RA, … , Freedman MS

April 22, 2024

Reply to the letter: Headaches during/after SARS-CoV-2 infection/vaccination can be primary and secondary as well as acute and chronic, by Finsterer J and Mehri S.

Mitsikostas DD, Caronna E, De Tommaso M, ... , Irimia-Sieira P.

April 16, 2024

Genetic causal relationship between immune diseases and migraine: a Mendelian randomization study.

Li G, Duan S, International Headache Genetics Consortium (IHGC), ..., Liu Z

April 8, 2024

Characteristics and outcomes of cerebral venous thrombosis associated with COVID-19

Scutelnic A, van de Munckhof A, Miraclin AT, ... , Heldner MR

April 4, 2024

Plasma brain-derived tau is an amyloid-associated neurodegeneration biomarker in Alzheimer's disease

Gonzalez-Ortiz F, Kirsebom BE, Contador J, … , Blennow K

April 4, 2024

Meeting Summary of The NYO3 5th NO-Age/AD Meeting and the 1st Norway-UK Joint Meeting on Aging and Cognitive impairment and dementia: Recent Progress on the Mechanisms and Interventional Strategies

Wang HL, Siow R, Schmauck-Medina T, Zhang J, ... , Fang EF

April 1, 2024

Assisting their orphaned children when in need'

Holmøy T

March 18, 2024

Repeat expansions in AR, ATXN1, ATXN2 and HTT in Norwegian patients diagnosed with amyotrophic lateral sclerosis

Novy C, Busk ØL, Tysnes OB, ... , Høyer H

March 14, 2024

Developing blood-brain barrier arterial spin labelling as a non-invasive early biomarker of Alzheimer's disease (DEBBIE-AD): a prospective observational multicohort study protocol

Padrela B, Mahroo A, Tee M, ... , Mutsaerts HJMM

March 8, 2024

Headaches and facial pain attributed to SARS-CoV-2 infection and vaccination: a systematic review

Mitsikostas DD, Caronna E, De Tommaso M, … , Irimia-Sieira P

February 28, 2024